Centocor seeks continuing damages in TNF patent case
08 January 2010
Nancy Faigen
Please Login to read the full article.
08 January 2010
Nancy Faigen
Johnson & Johnson's subsidiary Centocor has filed a new suit against Abbott Laboratories, seeking continuing damages as Abbott appeals a $1.85 billion judgement that its TNF inhibitor Humira (adalimumab) infringes a patent held by the J&J unit.
The complaint, filed on December...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Supreme Court to weigh generic drug liability, patent burden-of-proof standards
- Teva, Baxter continue to appeal $500M verdict in US hepatitis C propofol case
- US state judge upholds $327m verdict over J&J Risperdal marketing
- US Capitol Capsule: Court rulings in gene patent, stem cell cases provide new hope for biopharma
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
